Full Name

Triplet Therapeutics

Position

Former SVP, Development Operations

Quote

After taking everything into account - the manufacturing costs of a traditional CMO model, creating multiple lots of material that may never get used, etc. Quotient Sciences' Translational Pharmaceutics approach was a cost-effective option, especially when we took the additional cost of time saved into consideration.

Company

Triplet Therapeutics